Latest App Notes & Case Studies

This application note highlights the latest pulse system technology for quick and easy BAC analysis.

These materials highlight the use of single cell dispensers that enhance efficiency and predictability, improving workflow robustness to support safe and cost-effective biopharmaceutical manufacturing.

The global monoclonal antibody market is booming, but outdated analytical tools can delay the drug discovery race to be the first to deliver to patients.

In the quest for therapeutic or analytical antibodies, it is crucial to carefully select antibodies based on their kinetics, affinity, specificity and biophysical attributes. Antibody screening plays a pivotal role in identifying cell clones that generate antibodies suited to a specific purpose, often challenging these antibodies with a known antigen.

This application note demonstrates the successful identification of two low-abundance monoclonal antibodies using next-generation protein sequencing.

Monoclonal antibody (mAb)–based therapeutics have been very successful in treating various diseases, including cancer. The manufacturing of these therapeutic antibodies is a complex operation with low levels of aggregates being a critical quality attribute of the final product, as this will impact the biological activity.

In this app note, learn more about the advantages of batch centrifugation and how you can optimize downstream processing of primary T cells, and share some exemplary results for viability and recovery of T cells after washing and concentration.

This application note outlines how microalgal metabolism can be harnessed to produce novel food dyes with an automated screening approach.

Need a routine analytical technique that can provide protein expression profiling and targeted drug imaging? MALDI Imaging is used to determine the spatial distribution of molecules in a tissue section, for more complete multiomic information.

Many targets implicated in diseases are refractory to knockdown by traditional therapeutics like antibodies and small molecules. They represent an exciting new modality, repurposing small molecule chemical tools to achieve selective degradation